IPA canonical pathway analysis revealed significant enrichment in HER-2 signaling and estrogen-dependent breast cancer signaling, as well as other important cancer pathways such as PI3K/AKT signaling, PTEN signaling, and TGF-beta signaling (P < 0.0001, Figure 3 and Supplementary Table 3). This evidence concerns the gene ERBB2 and breast cancer.